image

Research

The Cardiovascular Innovation Institute (CII) is an internationally established research enterprise created to understand the mechanisms of heart, peripheral vascular and microcirculatory disease.  It is a collaboration between the University of Louisville and Jewish Hospital & St. Mary’s HealthCare.  The mission of the CII is to improve lives through world-class cardiovascular research, scientific discovery, and new enterprise creation.
learn more

 
image

Education

The CII enables students, faculty and staff to make lasting contributions to medical and biological research, create new knowledge and develop new technologies.  We are committed to the education and training of the next generation of clinicians and researchers.
learn more

 
image

Commercialization

The institute represents a multi-disciplinary research program.  The goal of the program is to address critical clinical problems in cardiovascular disease, to conduct research and translate this research from the bench to the bedside and support commercialization of discoveries.
learn more

 
image

Philanthropy

The CII uses gifts to provide funding for the latest advancements in research, attract and retain the best minds, and to expand laboratory facilities.
learn more

 

Since opening its doors in 2007, the Cardiovascular Innovation Institute (CII), a joint initiative between the University of Louisville and Jewish Hospital and St. Mary’s HealthCare has focused on the discovery, research, development and implementation of innovative treatments for cardiovascular disease. Our main goal is to foster a world-class collaborative, integrated, multi-disciplinary enterprise encompassing basic, translational, clinical, and population research in cardiovascular disease, affecting individuals throughout their entire lifespan, from pre-natal life to death. This is also the goal of the National Institutes of Health and has been identified as the most important area of medical research for the next decade.

Cardiovascular disease continues to be the number-one killer of Americans. Our researchers and staff are dedicated to reversing this statistic. We invite you to join our fight by learning more about our work, taking a tour of our labs and making a financial contribution that will save lives.